Stéphane Bancel

Chief Executive Officer

Stéphane Bancel has been Moderna's Chief Executive Officer since October 2011 and has 

served on Moderna’s board of directors since March 2011. Prior to joining Moderna, Mr. Bancel 

was the Chief Executive Officer of the diagnostics company bioMérieux SA for five years. From 

July 2000 to March 2006, he held various positions at Eli Lilly and Company, including 

Managing Director, Belgium, and Executive Director, Global Manufacturing Strategy and Supply 

Chain. Before his tenure at Eli Lilly, Mr. Bancel served as Asia-Pacific Sales and Marketing 

Director for bioMérieux. 

In addition to his role at Moderna, Mr. Bancel is a board member of Generate:Biomedicines and 

a Venture Partner at Flagship Pioneering. He holds a Master of Engineering degree from École 

Centrale Paris (ECP), a Master of Science in chemical engineering from the University of 

Minnesota, and an M.B.A. from Harvard Business School. 

In 2026, Mr. Bancel was named to the Forbes 250 Builders List, recognizing leaders who have 

helped shape American innovation and progress. He was nominated Chevalier of the Legion 

d'honneur in 2022, the highest recognition in France, and was elected to the U.S. National 

Academy of Engineering in 2024.